The US Food and Drug Administration appears uncertain as to whether COVID-19 vaccines for people under 12 should be granted an emergency use authorization or whether this indication must go through the full licensure process, preview documents released ahead of a 10 June agency advisory committee meeting on COVID vaccines in pediatrics indicate.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?